Isidró Ferrer

Active 1984–2025

Also published as
Isidro Ferrer
351
Papers
41,322
Citations
120
h-index
340
i10-index

Citations

Citations per year for Isidró Ferrer1967: 1 citations1971: 1 citations1990: 5 citations1991: 6 citations1992: 13 citations1993: 11 citations1994: 29 citations1995: 54 citations1996: 49 citations1997: 90 citations1998: 77 citations1999: 104 citations2000: 113 citations2001: 84 citations2002: 106 citations2003: 126 citations2004: 168 citations2005: 163 citations2006: 219 citations2007: 237 citations2008: 335 citations2009: 350 citations2010: 428 citations2011: 499 citations2012: 488 citations2013: 521 citations2014: 566 citations2015: 534 citations2016: 539 citations2017: 611 citations2018: 499 citations2019: 1,503 citations2020: 1,813 citations2021: 1,779 citations2022: 1,456 citations2023: 1,053 citations2024: 1,500 citations2025: 730 citations2026: 10 citations1968–1970: no citations, so these years are not shown1972–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,046 citing papers, 23.1% of this breakdownChina: 1,725 citing papers, 7.9% of this breakdownUnited Kingdom: 1,639 citing papers, 7.5% of this breakdownSpain: 1,441 citing papers, 6.6% of this breakdownGermany: 1,299 citing papers, 5.9% of this breakdownItaly: 1,228 citing papers, 5.6% of this breakdownCanada: 824 citing papers, 3.8% of this breakdownFrance: 742 citing papers, 3.4% of this breakdownAustralia: 618 citing papers, 2.8% of this breakdownJapan: 565 citing papers, 2.6% of this breakdownNetherlands: 553 citing papers, 2.5% of this breakdownIndia: 505 citing papers, 2.3% of this breakdown
0%23.1%Other 26%

Fields

  • Medicine48%
  • Biochemistry, Genetics and Molecular Biology29.3%
  • Neuroscience18%
  • Nursing1%
  • Immunology and Microbiology0.7%
  • Agricultural and Biological Sciences0.6%
  • Other2.4%

Topics

  • Alzheimer's disease research and treatments9.3%
  • Parkinson's Disease Mechanisms and Treatments5.1%
  • Neuroinflammation and Neurodegeneration Mechanisms4%
  • Neuroscience and Neuropharmacology Research3.1%
  • Mitochondrial Function and Pathology2.4%
  • Amyotrophic Lateral Sclerosis Research2.1%
  • Other74%

Coauthors

All papers

Open in search
  1. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giorgio Giaccone, Kimmo J. Hatanpaa, Richard Heale, Patrick R. Hof, Monika Hofer, Tibor Hortobágyi, K. A. Jellinger, Gregory A. Jicha, Paul G. Ince, Julia Kofler, Enikò Kövari, Jillian J. Kril, David Mann, Radoslav Matěj, Ann C. McKee, Catriona McLean, Ivan Milenković, Thomas J. Montine, Shigeo Murayama, Edward B. Lee, Jasmin Rahimi, Roberta Diehl Rodriguez, Annemieke J.M. Rozemüller, Julie A. Schneider, Christian Schultz, William W. Seeley, Danielle Seilhean, Colin Smith, Fabrizio Tagliavini, Masaki Takao, Dietmar Rudolf Thal, Jon B. Toledo, Markus Tolnay, Juan C. Troncoso, Harry V. Vinters, Serge Weis, Stephen B. Wharton, Charles L. White, Thomas Wısnıewskı, John Woulfe, Masahito Yamada, Dennis W. Dickson - Acta Neuropathologica 2015 cited by 530

  2. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roger N. Rosenberg, Charles L. White, Isidró Ferrer, Albert Lladó, Manuela Neumann, Hans A. Kretzschmar, Christine M. Hulette, Kathleen A. Welsh‐Bohmer, Bruce L. Miller, Ainhoa Alzualde, Adolfo López de Munain, Ann C. McKee, Marla Gearing, Allan I. Levey, James J. Lah, John Hardy, Jonathan D. Rohrer, Tammaryn Lashley, Ian R. Mackenzie, Howard Feldman, Ronald L. Hamilton, Steven T. DeKosky, Julie van der Zee, Samir Kumar‐Singh, Christine Van Broeckhoven, Richard Mayeux, Jean Paul Vonsattel, Juan C. Troncoso, Jillian J. Kril, John B. Kwok, Glenda M. Halliday, Thomas D. Bird, Paul G. Ince, Pamela J. Shaw, Nigel J. Cairns, John C. Morris, Catriona McLean, Charles DeCarli, William G. Ellis, Stefanie H. Freeman, Matthew P. Frosch, John H. Growdon, Daniel P. Perl, Mary Sano, David A. Bennett, Julie A. Schneider, Thomas G. Beach, Eric M. Reiman, Bryan K. Woodruff, Jeffrey L. Cummings, Harry V. Vinters, Carol A. Miller, Helena C. Chui, Irina Alafuzoff, Päivi Hartikainen, Danielle Seilhean, Douglas Galasko, Eliezer Masliah, Carl W. Cotman, MJ Tuñón, Mònica Martínez, David G. Muñoz, Steven L. Carroll, Daniel Marson, Peter Riederer, Nenad Bogdanović, Gerard D Schellenberg, Håkon Håkonarson, John Q. Trojanowski, Virginia M.‐Y. Lee - Nature Genetics 2010 cited by 609

  3. Clinical Correlations With Lewy Body Pathology inLRRK2-Related Parkinson Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charles Duyckaerts, Alexis Brice, A. Jon Stoessl, Connie Marras - JAMA Neurology 2014 cited by 407

  4. Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat

    Authors: , , , , , , , , , , , , , , - Nature 2012 cited by 1,030

  5. Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease

    Authors: , , , , , , , , , , , , , , , , - Stem Cell Reports 2019 cited by 376

  6. YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Molecular Neurodegeneration 2017 cited by 270

  7. Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Brain Pathology 2008 cited by 479

  8. Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains

    Authors: , , , , , , - Archives of Neurology 2010 cited by 537

  9. MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function

    Authors: , , , , , , , , , - Human Molecular Genetics 2011 cited by 483

  10. Altered Mitochondrial DNA Methylation Pattern in Alzheimer Disease–Related Pathology and in Parkinson Disease

    Authors: , , , , - American Journal Of Pathology 2016 cited by 190

  11. Severe Alterations in Lipid Composition of Frontal Cortex Lipid Rafts from Parkinson’s Disease and Incidental Parkinson’s Disease

    Authors: , , , , , , - Molecular Medicine 2011 cited by 381

  12. Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Autophagy 2018 cited by 152

  13. Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2009 cited by 329

  14. Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia

    Authors: , , , , , , , , , , , , , , , , , - Nature Communications 2020 cited by 118

  15. Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis

    Authors: , , , , , , , , , - Brain 2007 cited by 354

  16. Proteomic and oxidative stress analysis in human brain samples of Huntington disease.

    Authors: , , , , , - 2008 cited by 298

  17. Lipidomics of Human Brain Aging and Alzheimer's Disease Pathology

    Authors: , , , , , , , - International review of neurobiology 2015 cited by 192

  18. (Patho‐)physiological relevance of PINK1‐dependent ubiquitin phosphorylation

    Authors: , , , , , , , , , , , , , , , , , , , - EMBO Reports 2015 cited by 188

  19. Hypothesis review: Alzheimer's overture guidelines

    Authors: - Brain Pathology 2022 cited by 57

  20. A myriad of miRNA variants in control and Huntington’s disease brain regions detected by massively parallel sequencing

    Authors: , , , , , , , , - Nucleic Acids Research 2010 cited by 325

  21. Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic

    Authors: , - Frontiers in Pharmacology 2014 cited by 231

  22. Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Human Molecular Genetics 2018 cited by 187

  23. Neuroprotective Role of Trans-Resveratrol in a Murine Model of Familial Alzheimer's Disease

    Authors: , , , , , , - Journal of Alzheimer s Disease 2014 cited by 175

  24. Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies

    Authors: , , , , , , - Frontiers in Aging Neuroscience 2019 cited by 77